
Summit Therapeutics Inc
NASDAQ:SMMT

Fundamental Analysis

Summit's lead antibiotic candidate, ridinilazole, faces heightened regulatory uncertainty after mixed trial data, casting doubt on its commercial viability and threatening the company’s near-term revenue prospects.
Ridinilazole’s focus on addressing C. difficile infection with a targeted mechanism of action could earn it a first-in-class profile, positioning Summit for significant market share in a vital therapeutic area.

Revenue & Expenses Breakdown
Summit Therapeutics Inc
Balance Sheet Decomposition
Summit Therapeutics Inc
Current Assets | 423.8m |
Cash & Short-Term Investments | 412.3m |
Receivables | 557k |
Other Current Assets | 10.8m |
Non-Current Assets | 11.8m |
PP&E | 7.4m |
Intangibles | 1.9m |
Other Non-Current Assets | 2.5m |
Free Cash Flow Analysis
Summit Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Summit Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-211m
USD
|
Operating Income
|
-211m
USD
|
Other Expenses
|
-10.3m
USD
|
Net Income
|
-221.3m
USD
|
SMMT Profitability Score
Profitability Due Diligence
Summit Therapeutics Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Score
Summit Therapeutics Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.
SMMT Solvency Score
Solvency Due Diligence
Summit Therapeutics Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Score
Summit Therapeutics Inc's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SMMT Price Targets Summary
Summit Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
SMMT
is 38.12 USD
with a low forecast of 30.3 USD and a high forecast of 46.2 USD.
Dividends
Current shareholder yield for SMMT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?